Novavax (NVAX)
9.57
-0.62 (6.08%)
Upcoming Events
Latest Headlines
Novavax to Participate in 2026 Jefferies Global Healthcare Conference
June 1, 2026 4:00 PM - PR NewsWire
Form 144 NOVAVAX INC Filed by: Draghia-Akli Ruxandra
May 27, 2026 4:42 PM - SEC Filing
Form SCHEDULE 13D/A NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT
May 15, 2026 8:15 AM - SEC Filing
Form 144 NOVAVAX INC Filed by: Draghia-Akli Ruxandra
May 7, 2026 5:04 PM - SEC Filing
Novavax to Participate in BofA Securities 2026 Health Care Conference
May 7, 2026 4:00 PM - PR NewsWire
Novavax (NVAX) Tops Q1 EPS by 18c; offers guidance
May 6, 2026 8:27 AM - StreetInsider
Novavax (NVAX) PT Raised to $9 at TD Cowen
May 6, 2026 8:20 AM - StreetInsider
Form 8-K NOVAVAX INC For: May 06
May 6, 2026 8:00 AM - SEC Filing
Novavax Reports First Quarter 2026 Financial Results and Operational Highlights
May 6, 2026 8:00 AM - PR NewsWire
Form 10-Q NOVAVAX INC For: Mar 31
May 6, 2026 7:51 AM - SEC Filing
Form SCHEDULE 13G NOVAVAX INC Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 30, 2026 12:07 PM - SEC Filing
Novavax to Report First Quarter 2026 Financial Results on May 6, 2026
April 29, 2026 4:00 PM - PR NewsWire
Form 4 NOVAVAX INC For: Apr 25 Filed by: Newton Charles W.
April 28, 2026 5:00 PM - SEC Filing
Form SCHEDULE 13G/A NOVAVAX INC Filed by: BANK OF AMERICA CORP /DE/
April 27, 2026 1:03 PM - SEC Filing
Form ARS NOVAVAX INC For: Dec 31
April 27, 2026 10:10 AM - SEC Filing
Form DEFA14A NOVAVAX INC
April 27, 2026 8:01 AM - SEC Filing
Form DEF 14A NOVAVAX INC For: Jun 18
April 27, 2026 8:00 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Novavax (NVAX)
April 21, 2026 6:38 AM - StreetInsider
Form 4 NOVAVAX INC For: Apr 14 Filed by: Walker Robert Edward
April 16, 2026 6:13 PM - SEC Filing
Form 3 NOVAVAX INC For: Apr 14 Filed by: Walker Robert Edward
April 16, 2026 5:40 PM - SEC Filing
Novavax (NVAX) PT Raised to $18 at B.Riley
April 9, 2026 6:56 AM - StreetInsider
Shah Capital urges vote against Novavax board and pay
April 8, 2026 6:11 AM - StreetInsider
Form SCHEDULE 13D/A NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT
April 8, 2026 6:05 AM - SEC Filing
Novavax promotes Robert Walker to head research and development
March 30, 2026 8:01 AM - StreetInsider
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development
March 30, 2026 8:01 AM - PR NewsWire
Form SCHEDULE 13G/A NOVAVAX INC Filed by: VANGUARD GROUP INC
March 27, 2026 11:07 AM - SEC Filing
US Judge blocks Trump Admin cuts to number of routinely recommended vaccines for children - Reuters
March 16, 2026 3:46 PM - StreetInsider
Form 4 NOVAVAX INC For: Mar 10 Filed by: Shiver John W.
March 12, 2026 5:01 PM - SEC Filing
Jefferies Reiterates Buy Rating on Novavax (NVAX): "capital-light adjuvant platform with improving line-of-sight"
March 12, 2026 2:58 PM - StreetInsider
Form 4 NOVAVAX INC For: Mar 07 Filed by: Kelly James Patrick
March 9, 2026 6:14 PM - SEC Filing
Form 4/A NOVAVAX INC For: Mar 02 Filed by: Kelly James Patrick
March 9, 2026 6:12 PM - SEC Filing
Form 4/A NOVAVAX INC For: Mar 02 Filed by: Draghia-Akli Ruxandra
March 9, 2026 6:11 PM - SEC Filing
Form 4/A NOVAVAX INC For: Mar 02 Filed by: Casey Mark J
March 9, 2026 6:10 PM - SEC Filing
Form 4/A NOVAVAX INC For: Mar 02 Filed by: Jacobs John C
March 9, 2026 6:08 PM - SEC Filing
Form 4/A NOVAVAX INC For: Mar 02 Filed by: O'Hara Elaine
March 9, 2026 6:06 PM - SEC Filing
Full Article List